Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery From Substance Use Disorder: Phase II

NCT05227339 is registered in ClinicalTrials.gov with ContinueYou, LLC as lead sponsor.

NCT NCT05227339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery From Substance Use Disorder: Phase II
Lead sponsor
ContinueYou, LLC
Phase
Phase 2/3
Overall status
Completed
Start date
February 22, 2022
Completion date
April 1, 2024
Enrollment
209 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

substance use disorders, treatment adherence and compliance